Ixico plc Chief Commercial Officer Lammert Albers joined Steve Darling from Proactive to share news the Clinical Research Organization has awarded the company, on behalf of their biopharmaceutical sponsor, a 6-figure deal to conduct a Phase II Alzheimer’s disease clinical trial.
Albers talks about that contract and also shares with Proactive about some of the other contracts they have secured over the past few weeks.